Skip to search formSkip to main contentSkip to account menu

tumor cell derivative vaccine

Known as: tumor antigen vaccine, tumor vacc, vaccine, tumor cell derivative 
A vaccine made of cancer cells, parts of cancer cells, or pure tumor antigens (substances isolated from tumor cells). A tumor antigen vaccine may… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Cancer VaccinesVaccines
Vaccine Therapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract B120: Characterization and combination immunotherapy treatment of an inducible autochthonous murine lung cancer model expressing human carcinoembryonic antigen (CEA) as a tumor-associated…
Previous work from our lab has demonstrated that a combination of anti-tumor antibody and an IL-2 fusion protein that exhibits… 
2015
2015
Autologous oxidized whole-tumor antigen vaccine in combination with angiogenesis blockade to elicit antitumor immune response in ovarian cancer.
5519 Background: Personalized tumor lysate vaccines can encompass all putative antigens in tumors. Methods: A pilot clinical… 
2013
2013
A phase-I trial of a novel autologous oxidized whole-tumor antigen vaccine therapy for recurrent ovarian cancer
2013
2013
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
Ovarian cancer, like most solid tumors, is in dire need of effective therapies. The significance of this trial lies in its… 
2012
2012
A novel autologous oxidized whole-tumor antigen vaccine therapy for recurrent ovarian cancer.
5023 Background: Despite surgical and chemotherapeutic advances, the death rate from ovarian cancer has not changed. We report… 
2011
2011
In silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancer
Multiple different approaches are being used to activate the immune system against breast cancer. Vaccine therapy in general… 
Review
2005
Review
2005
Identification and characterization of human hepatocellular carcinoma-associated antigens
Hepatocellular carcinoma (HCC) ranks the second to the third highest incidence of cancers and the second highest cause of cancer… 
1986
1986
Preparation and characterization of a polyvalent human melanoma antigen vaccine.
A polyvalent melanoma tumor antigen vaccine was prepared from antigens shed by a pool of human melanoma cells cultured in serum… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)